Drugs / TetraVax-DV Vaccine-Admixture 2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01072786 | Jul 2010 → Jun 2012 | dengue disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TetraVax-DV Vaccine-Admixture 2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01072786 ↗ |
| Modality | Vaccine | “a recombinant live attenuated tetravalent dengue virus vaccine” NCT01072786 ↗ |
| Route | Subcutaneous | “One subcutaneous injection of a recombinant live attenuated TetraVax-DV vaccine, admixture 2” NCT01072786 ↗ |